A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?

Nutrition Research Reviews

Volumn 18, Issue 2, 2005, Pages 175-182

  Flores, Mario ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

C reactive protein; Insulin resistance; Type 2 diabetes; Vitamin D

Indexed keywords

CALCITRIOL; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; RISK FACTOR;

EID: 31144460813     PISSN: 09544224     EISSN: None     Source Type: Journal    
DOI: 10.1079/NRR2005104     Document Type: Review

References (81)

1. Adorini L (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Annals of the New York Academy of Sciences 987, 258-261.
2. 3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells. Pharmacology and Toxicology 92, 204-213.
3. Arunabh S, Pollack S, Yeh J & Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. Journal of Clinical Endocrinology and Metabolism 88, 157-161.
4. Barzilay JL, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE & Tracy RP (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50, 2384-2389.
5. Bays H, Mandarino L & DeFronzo RA (2004) Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Journal of Clinical Endocrinology and Metabolism 89, 463-478.
6. Becker BN, Hullet DA, O'Herrin JK, Malin G, Sollinger HW & DeLuca H (2002) Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation 74, 1204-1206.
7. Berger B, Stenstrom G & Sundkvist G (1999) Incidence, prevalence, and mortality of diabetes in a large population: a report from the Skaraborg Diabetes Registry. Diabetes Care 22, 773-777.
8. Bermudez EA, Rifai N, Buring J, Manson JA & Ridker PM (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arteriosclerosis, Thrombosis and Vascular Biology 22, 1668-1673.
9. Beutler B, Mahoney J, Le Trang N, Pekala P & Cerami A (1985) Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264. Journal of Experimental Medicine 161, 984-995.
10. Beutler BA & Cerami A (1985) Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. Journal of Immunology 135, 3969-3971.
11. Borissova AM, Tankova T, Kirilov G, Dakovska L & Kovacheva R (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. International Journal of Clinical Practice 57, 258-261.
12. Boucher BJ, Mannan N, Noonan K, Hales CN & Evans SJ (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 1239-1245.
13. Cantorna MT, Zhu Y, Froicu M & Wittke A (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. American Journal of Clinical Nutrition 80, Suppl., 1717S-1720S.
14. Centers for Disease Control and Prevention (2003) National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2002. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, http://www.diabetes.org/diabetes-statistics/ national-diabetes-fact-sheet.jsp
15. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH & Bryer-Ash M (1998) An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNF-α)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-α. Endocrinology 139, 4928-4935.
16. Chiu KC, Chu A, Go VLW & Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. American Journal of Clinical Nutrition 79, 820-825.
17. Chiu KC, Chuang L-M, Martinez DS & Yoon C (2001a) Serum 25-hydroxyvitamin D concentration is a key determinant for insulin sensitivity. Diabetes 50, A512.
18. Chiu KC, Chuang L-M, Yoon C & Chu A (2001b) The impact of the FokI polymorphism at the vitamin D receptor gene on insulin sensitivity and beta cell function. Diabetes 50, Suppl. 2, A234.
19. Das UN (2001) Is obesity an inflammatory condition? Nutrition 17, 953-966.
20. DeLuca HF & Zierold C (1998) Mechanisms and functions of vitamin D. Nutrition Reviews 56, S4-S10.
21. Engström G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L & Lindgarde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality of myocardial infarction and stroke: a population-based study. Diabetes 52, 442-447.
22. Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G & Giugliano D (2003) Association of low interleukin-10 levels with the metabolic syndrome in obese women. Journal of Clinical Endocrinology and Metabolism 88, 1055-1058.
23. Fernandez-Real JM, Broch M, Vendrell J & Rieart W (2000) Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. Journal of Clinical Endocrinology and Metabolism 85, 1334-1339.
24. Ford ES (2002) Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. American Journal of Epidemiology 155, 57-64.
25. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ Sattar N & West of Scotland Coronary Prevention Study (2002) C-reactive protein is an independent predictor of risk of the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51, 1596-1600.
26. Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, et al. (2001) Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103, 357-362.
27. Gewurz H, Zhang XH & Lint TF (1995) Structure and function of the pentraxins. Current Opinion in Immunology 7, 54-64.
28. Han TS, Sattar N, Williams K, González-Villalpando C, Lean ME & Haffner SM (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25, 2016-2021.
29. Harant H, Spinner D, Reddy GS & Lindley IJ (2000) Natural metabolites of 1-alpha, 25-dihydroxyvitamin D3 retain biologic activity mediated through the vitamin D receptor. Journal of Cellular Biochemistry 78, 112-120.
30. Harant H, Wolff B & Lindley IJ (1998) 1-Alpha, 25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Letters 436, 239-334.
31. Hewison M, Zehnder D, Chakraverty R & Adams JS (2004) Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Molecular and Cellular Endocrinology 215, 31-38.
32. Higashimori T, Kim H-J, Choi H, Liu Z-X, Dong J, Kim Y-K, Non H-L, Kim Y-B & Jason K (2003) Interleukin-6 induces insulin resistance in skeletal muscle and liver in vivo. Diabetes 52, A422.
33. Holick MF (2004a) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 80, Suppl., 1678S-1688S.
34. Holick MF (2004b) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 79, 362-371.
35. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE & Shulman GI (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Journal of Clinical Investigation 109, 1321-1326.
36. Isaia G, Giorgino R & Adami S (2001) High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes 24, 1496.
37. Ishimura E, Nishizawa Y, Koyama H, Shoji S, Inaba M & Morii H (1995) Impaired vitamin D metabolism and reponse in spontaneously diabetic GK rats. Mineral and Electrolyte Metabolism 21, 205-210.
38. Jiang C, Ting AT & Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
39. Kadowaki S & Norman AW (1985) Demonstration that the vitamin D metabolite 1,25(OH)2-D3 and not 24R,25(OH)2-D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34, 315-320.
40. Kershaw EE & Flier JS (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 89, 2548-2556.
41. Kim H-J, Higashimori T, Choi H, Liu Z-X, Dong J, Kim Y-K, Noh H-L, Kim Y-B & Jason K (2003) Pre-treatment of interleukin-10 prevents lipid-induced and interleukin-6-induced insulin resistance in vivo. Diabetes 52, A290.
42. Klover P, Zimmers T, Koniaris L & Mooney RA (2003) Acute or chronic exposure to interleukin-6 induces hepatic insulin resistance in vivo. Diabetes 52, A290.
43. Koj A, Magielska-Zero D, Bereta J, Kurdowska A, Rokita H & Gauldie J (1988) The cascade of inflammatory cytokines regulating synthesis of acute phase proteins. Journal of Experimental Medicine 13, 255-264.
44. Lagraine C & Lebranchu Y (2003) Effects of immunosupressive drugs on dendritic cells and tolerance induction. Transplantation 75, 37S-42S.
45. Lemire JM (1995) Immunomodulatory actions of 1,25-dihydroxivitamin D3. Journal of Steroid Biochemistry and Molecular Biology 53, 599.
46. Lemire JM, Archer DC, Beck L & Spiegelberg HL (1995) Immunosuppressive actions of 1,25-dihydroxy vitamin D3: preferential inhibition of Th1 functions. Journal of Nutrition 125, 1704S-1708S.
47. Long KZ & Santos JI (1999) Vitamins and the regulation of the immune response. Pediatric Infectious Disease Journal 18, 283-290.
48. Mahon BD, Wittke A, Weaver V & Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry 89, 922-932.
49. Matheu V, Back O, Mondoc E & Issazadeh-Navikas S (2003) Dual effects of vitamin D-induced alteration of Th1/Th2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. Journal of Allergy and Clinical Immunology 112, 585-592.
50. Mathieu C, Jos L, Halina S, Michel V, Mark W & Roger B (1992) 1,25-dihydroxivitamin D3 prevents insulitis in NOD mice. Diabetes 41, 1491-1495.
51. O'Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A & Koeffler HP (2002) Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. Journal of Clinical Investigation 109, 1091-1099.
52. Ogunkolade B-J, Boucher B, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF & Hitman GA (2002) Vitamin D receptor (VDR) mRNA and protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51, 2294-2300.
53. Oh JY & Barrett-Connor E (2002) Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51, 356-359.
54. Papanicolaou D (2000) Editorial: Interleukin-6: the endocrine cytokine. Journal of Clinical Endocrinology and Metabolism 85, 1331-1333.
55. Parikh S, Edelman M, Semega-Janneh M, Freedman R, Calis K & Yanovski J (2003) Relationships between calcitropic hormones and measures of insulin sensitivity in overweight adults. Diabetes 52, A293.
56. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J & Yanovski JA (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. Journal of Clinical Endocrinology and Metabolism 89, 1196-1199.
57. Pepys MB & Hirschfield GM (2003) C-reactive protein: a critical update. Journal of Clinical Investigation 111, 1805-1812.
58. Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M & Willheim M (2002) 1α,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatric Research 52, 12-18.
59. Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes mellitus. Diabetes Care 27, 813-823.
60. Pittas A, Joseph NA & Greenberg A (2004) Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism 89, 447-452.
61. Pradhan AD, Manson JE, Rifai N, Buring JE & Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
62. Raiten DJ & Picciano MF (2004) Vitamin D and health in the 21st century: bone and beyond. Executive summary. American Journal of Clinical Nutrition 80, Suppl., 1673S-1677S.
63. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
64. Rotter V, Nagaev I & Smith U (2003) Interleukin-6 (IL-6) reduces gene and protein expression of IRS-1 and GLUT4 and is overexpressed in human fat cells from insulin-resistant subjects. Diabetes 51, A303.
65. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP & Heiss G (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353, 1649-1652.
66. Scragg R, Sowers M & Bell C (2004) Serum 25-hydroxivitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813-2818.
67. Senn JJ, Klover PJ, Nowak IA & Mooney RA (2002) Interleukin-6 induces cellular insulin-resistance in hepatocytes. Diabetes 51, 3391-3399.
68. Smith JK, Dykes R, Douglas JE, Krishnaswami G & Berk S (1999) Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281, 1722-1727.
69. Stevenson MA, Zhao MJ, Asea A, Coleman CN & Calderwood SK (1999) Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-[kappa]B-responsive genes. Journal of Immunology 163, 5608-5616.
70. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, Aganna E, Price CP & Boucher BJ (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95, 787-796.
71. Tracey KJ & Cerami A (1990) Metabolic responses to cachectin/TNF: a brief review. Annals of the New York Academy of Sciences 587, 325-331.
72. Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. American Journal of Clinical Nutrition 69, 842-856.
73. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C & Tataranni PA (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51, 455-461.
74. Weaver CM & Fleet JC (2004) Vitamin D requirements: current and future. American Journal of Clinical Nutrition 80, Suppl., 1735S-1739S.
75. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW (2003) Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112, 1796-1808.
76. Worstman J, Matsuoka LY, Chen TC, Lu Z & Holick MF (2000) Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition 72, 690-693.
77. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA & Chen H (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 112, 1821-1830.
78. Yuan M, Kostantopoulos N, Lee J, Hansen L, Li ZW, Karin M & Shoelson SE (2001) Reversal of obesity and diet-induced insulin resitance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677.
79. Yudkin JS, Stehouwer CD, Emeis JJ & Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis and Vascular Biology 19, 972-978.
80. Yusuf S, Sleight P, Pogue J, Davies R & Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine 342, 145-153.
81. Zittermann A (2003) Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition 89, 552-572.